February 21, 2025

AAN: Limited Benefits Found for Epidural Steroid Injections

New systematic review from the American Academy of Neurology finds epidural steroid injections offer modest short-term benefits but limited long-term efficacy for treating spinal pain conditions, with varying results across different applications.

Conexiant

February 21, 2025

Salt, Sour Taste Loss Raises Mortality Risk

Research shows that adults experiencing perceived taste loss face a higher risk of mortality, particularly when the ability to detect salt and sourness declines.

Conexiant

February 18, 2025

Independent Associations Between Trauma, PTSD, and Endometriosis Risk

Researchers examine the independent associations between traumatic experiences, genetic predisposition, and endometriosis risk using observational and genomic analyses.

Conexiant

February 18, 2025

Fraudulent Pain Injections Tied to Opioid Access

A pain management company, Pain MD, exploited patients' opioid dependence through unnecessary 'tendon origin injections,' leading to a decade-long fraud scheme. The injections, largely ineffective and over-administered, raised millions. The president, Michael Kestner, faced multiple felony charges, reflecting a concerning intersection of opioid dependency and healthcare fraud.

KFF Health News

February 18, 2025

Nystagmus Patterns and Mobile Video in Menière’s Disease: Study Insights

Researchers examine nystagmus patterns in Menière’s disease and evaluate mobile phone video recordings for vertigo diagnosis, while also reporting on labyrinthectomy outcomes in select patients.

Conexiant

February 13, 2025

Longer Balance Tests Better Predict Falls

New research suggests extending standard balance assessment times from 10 to 23 seconds more accurately identifies fall risk in older adults. Plus, stance maintenance could serve as a key predictor of future falls.

Conexiant

February 12, 2025

Psychiatrist Settles False Claims, Controlled Substances Allegations

A Connecticut psychiatrist agreed to a $455K settlement after an investigation identified fraudulent Medicare claims and unsafe controlled substance prescribing practices, resulting in DEA sanctions and a 20-year exclusion from federal health programs.

Conexiant

February 12, 2025

Phase III Trial Targets Venous Leg Ulcers

With no new FDA-approved drugs for chronic wound debridement since 1965, MediWound's phase 3 trial tests EscharEx for venous leg ulcers in 216 patients.

Reuters

February 07, 2025

Long-Term Rise in Cannabis-Associated Schizophrenia Cases, Predating Legalization

Researchers found that the proportion of schizophrenia cases linked to cannabis use disorder nearly tripled post-legalization, with the highest impact among young males.

Conexiant